HRH2 and gastroesophageal reflux disease: Moreover, the removal from the market of all formulations containing the histamine H2-receptor antagonist ranitidine, which was widely used in the treatment of GERD and other conditions involving acid reflux into the esophagus, has been contributed to direct the research towards the development of new products.